N/A
N=778
Doctors' Understanding of Survival Statistics
Screening
Bottom Line
View on ClinicalTrials.gov: NCT00981019 ↗Enrolled (actual)
778
Serious AEs
—
Results posted
Aug 2011
Primary outcome: Primary: Number of Physicians (=Participants) Recommending the Screening — 301 participants — p=<0.05
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 30+ yrs
- Sex
- All
- Sponsor
- Max Planck Institute for Human Development
- Primary completion
- Dec 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Physicians (=Participants) Recommending the Screening |
301 | <0.05 sig |
| SECONDARY Number of Physicians (= Participants) Assuming a Benefit of Screening |
— | — |
Summary
The probably most commonly used measure for expressing the pay-offs of early detection and treatment are survival rates. Yet, over time and groups this metric comes with several biases and thus, is not reliable for judging such benefits. Epidemiologists recommend using reduction of disease-specific mortality rates instead, which is unbiased. The purpose of the study is to investigate how primary care physicians understand and use different survival measures for determining the benefit of cancer screening tests.
Eligibility Criteria
Inclusion Criteria
- primary care physicians (internal, general, and family medicine physicians)
Exclusion Criteria
- all other types of physicians
Data sourced from ClinicalTrials.gov (NCT00981019). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.